Daniel Röshammar, Martin Bergstrand and Moustafa Ibrahim, of Pharmetheus are co-authors to the publication ‘Pharmacokinetic Modeling and Simulation Support for Age‐ and Weight‐Adjusted Dosing of Dabigatran Etexilate in Children with Venous Thromboembolism (VTE)’, accepted in
We’re extending a warm welcome to Johanna, who joined our growing PBPK team as an Associate Consultant. Johanna’s research experience includes PBPK modelling of pulmonary drug absorption for different formulations in both
Sven is Pharmetheus’ new Support Manager. He is an experienced Helpdesk manager with a background in IT Support and Infrastructure Processes. We’re honoured to have him join us! See Sven’s bio here.
Marylore joins Pharmetheus from a position as Head of Global Pharmacometrics & Clinical Pharmacokinetics at Servier. Marylore has great depth of expertise in pharmacometrics and is a recognized leader in the implementation
We are happy to have Annika onboard as a QC/Medical Writer Consultant. Her experience includes clinical pharmacology study design and execution, as well as writing clinical documents for regulatory submissions. Annika is
We want to congratulate Christine Wegler, winner of the (co-sponsored by Pharmetheus), presented by the Swedish Pharmaceutical Society today. Read more here (in Swedish).
Pharmetheus continues to monitor the challenges presented by the COVID-19 pandemic and its effects on our company and in the field of clinical drug development. Read more about our approach and latest updates here.
Our CEO, Dr Peter A Milligan, has been interviewed by the Pharma Tech Outlook magazine. Read more about how we change the model informed drug development landscape of the pharmaceutical industry with
We are honoured that Pharmetheus has been listed as one of the top 10 pharma analytics companies in Europe by the Pharma Tech Outlook magazine for our Model Informed Drug Development consulting
Pharmetheus offers consulting services focused on the application of quantitative approaches to support drug development decisions..
